202 related articles for article (PubMed ID: 34983327)
1. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
Zhang W; Liu C; Li J; Lu Y; Li H; Zhuang J; Ren X; Wang M; Sun C
Am J Chin Med; 2022; 50(1):209-239. PubMed ID: 34983327
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.
Alam SSM; Samanta A; Uddin F; Ali S; Hoque M
Pharmacol Rep; 2023 Aug; 75(4):907-922. PubMed ID: 37440106
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway.
Zhang W; Liu M; Ji Y; Yu D; Ma C; Zhao J; Qu P
Arch Biochem Biophys; 2023 Jul; 743():109655. PubMed ID: 37285895
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
5. Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway.
Zhang X; Li S; Chen Z; Liang W; Pei S; Gou F; Jia Z; Geng Z; Gong X
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37800602
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
[TBL] [Abstract][Full Text] [Related]
7. Study on optimisation of extraction process of tanshinone IIA and its mechanism of induction of gastric cancer SGC7901 cell apoptosis.
Hou J; He J; Jin X; Hu T; Zhang Y
Afr J Tradit Complement Altern Med; 2013; 10(6):456-8. PubMed ID: 24311868
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes.
HONG HJ; LIU JC; CHENG TH; CHAN P
Acta Pharmacol Sin; 2010 Dec; 31(12):1569-75. PubMed ID: 21102479
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
11. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen).
Chang CC; Lai JS; Tsai CS; Ma SW; Lin JY; Huang LR; Lu CH; Liao EC; Ho TF
J Biosci Bioeng; 2013 Oct; 116(4):516-23. PubMed ID: 23660075
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells.
Yang LJ; Jeng CJ; Kung HN; Chang CC; Wang AG; Chau GY; Don MJ; Chau YP
J Biomed Sci; 2005; 12(2):347-61. PubMed ID: 15917998
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.
Liao XZ; Gao Y; Huang S; Chen ZZ; Sun LL; Liu JH; Chen HR; Yu L; Zhang JX; Lin LZ
Phytother Res; 2019 Sep; 33(9):2298-2309. PubMed ID: 31268205
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway.
Ma L; Jiang H; Xu X; Zhang C; Niu Y; Wang Z; Tao Y; Li Y; Cai F; Zhang X; Wang X; Yu Y
Aging (Albany NY); 2019 Nov; 11(21):9719-9737. PubMed ID: 31711043
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
Deng H; Yu B; Li Y
Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.
Hong HJ; Liu JC; Chen PY; Chen JJ; Chan P; Cheng TH
Int J Cardiol; 2012 May; 157(2):174-9. PubMed ID: 21190747
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
[TBL] [Abstract][Full Text] [Related]
18. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway.
Liu M; Yang J; Li M
Clinics (Sao Paulo); 2015 Apr; 70(4):250-6. PubMed ID: 26017791
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms.
Huang J; Zhang J; Sun C; Yang R; Sheng M; Hu J; Kai G; Han B
J Ethnopharmacol; 2024 Jan; 318(Pt B):117022. PubMed ID: 37572929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
